| Metric | Q2 2027 | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 |
|---|---|---|---|---|---|
| Revenue | 3.0B -4.1% | 3.2B -18.8% | 3.9B +36.4% | 2.9B +2.5% | 2.8B |
| Cost of Revenue | 1.8B -2.5% | 1.9B -21.5% | 2.4B +41.9% | 1.7B +0.3% | 1.7B |
| Gross Profit | 1.2B -6.4% | 1.3B -14.6% | 1.5B +28.4% | 1.2B +5.9% | 1.1B |
| Operating Expenses | 807.3M -1.5% | 819.4M -18.6% | 1.0B +19.0% | 846.2M +13.3% | 746.8M |
| R&D | 0 | 0 | 0 | 0 | 0 |
| SG&A | 802.8M -1.5% | 814.7M -18.8% | 1.0B +19.3% | 840.9M +13.4% | 741.7M |
| Operating Income | 379.6M -15.3% | 448.3M -6.0% | 476.9M +54.1% | 309.4M -10.3% | 344.9M |
| EBITDA | 461.0M -13.0% | 529.7M -5.2% | 558.7M +45.0% | 385.2M -7.4% | 416.0M |
| Net Income | 282.0M -17.2% | 340.5M -4.5% | 356.7M +54.5% | 230.9M -11.5% | 260.9M |
| EPS (Basic) | $6.57 -15.6% | $7.78 -3.4% | $8.05 +56.0% | $5.16 -11.0% | $5.80 |
| EPS (Diluted) | $6.55 -15.4% | $7.74 -3.5% | $8.02 +56.0% | $5.14 -11.1% | $5.78 |
| Shares (Diluted) | 43.1M -2.1% | 44.0M -1.1% | 44.4M -1.0% | 44.9M -0.5% | 45.1M |